Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Expression of the Hepatitis B Virus Genome in Chronic Hepatitis B Carriers and Patients with Hepatocellular Carcinoma

Autor: Bowyer, S. M., Dusheiko, G. M., Schoub, B. D., Kew, M. C.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 1987 Feb 01. 84(3), 847-850.

Externí odkaz: https://www.jstor.org/stable/28825

The case for simplifying and using absolute targets for viral hepatitis elimination goals

Autor: Razavi, H. Blach, S. Razavi-Shearer, D. Abaalkhail, F. Abbas, Z. Abdallah, A. Abrao Ferreira, P. Abu Raddad, L.J. Adda, D. Agarwal, K. Aghemo, A. Ahmed, A. Al-Busafi, S.A. Al-hamoudi, W. Al-Kaabi, S. Al-Romaihi, H. Aljarallah, B. AlNaamani, K. Alqahtani, S. Alswat, K. Altraif, I. Asselah, T. Bacon, B. Bessone, F. Bizri, A.R. Block, T. Bonino, F. Brandão-Mello, C.E. Brown, K. Bruggmann, P. Brunetto, M.R. Buti, M. Cabezas, J. Calleja, J.L. Castro Batänjer, E. Chan, H.L.-Y. Chang, H. Chen, C.-J. Christensen, P.B. Chuang, W.-L. Cisneros, L. Cohen, C. Colombo, M. Conway, B. Cooper, C. Craxi, A. Crespo, J. Croes, E. Cryer, D. Cupertino de Barros, F.P. Derbala, M. Dillon, J. Doss, W. Dou, X. Doyle, J. Duberg, A.-S. Dugan, E. Dunn, R. Dusheiko, G. El Khayat, H. El-Sayed, M.H. Eshraghian, A. Esmat, G. Esteban Mur, R. Ezzat, S. Falconer, K. Fassio, E. Ferrinho, P. Flamm, S. Flisiak, R. Foster, G. Fung, J. García-Samaniego, J. Gish, R.G. Gonçales, F. Halota, W. Hamoudi, W. Hassany, M. Hatzakis, A. Hay, S. Himatt, S. Hoepelman, I.M. Hsu, Y.-C. Hui, Y.T. Hunyady, B. Jacobson, I. Janjua, N. Janssen, H. Jarcuska, P. Kabagambe, K. Kanto, T. Kao, J.-H. Kaymakoglu, S. Kershenobich, D. Khamis, F. Kim, D.J. Kim, D.Y. Kondili, L.A. Kottilil, S. Kramvis, A. Kugelmas, M. Kurosaki, M. Lacombe, K. Lagging, M. Lao, W.-C. Lavanchy, D. Lazarus, J.V. Lee, A. Lee, S.S. Levy, M. Liakina, V. Lim, Y.-S. Liu, S. Maddrey, W. Malekzadeh, R. Marinho, R.T. Mathur, P. Maticic, M. Mendes Correa, M.C. Mera, J. Merat, S. Mogawer, S. Mohamed, R. Muellhaupt, B. Muljono, D. Mostafa, I. Nahum, M.S. Nawaz, A. Negro, F. Ninburg, M. Ning, Q. Ntiri- Reid, B. Nymadawa, P. Oevrehus, A. Ormeci, N. Orrego, M. Osman, A. Oyunsuren, T. Pan, C. Papaevangelou, V. Papatheodoridis, G. Popping, S. Prasad, P. Prithiviputh, R. Qureshi, H. Ramji, A. Razavi-Shearer, K. Reddy, R. Remak, W. Richter, C. Ridruejo, E. Robaeys, G. Roberts, S. Roberts, L. Roudot-Thoraval, F. Saab, S. Said, S. Salamat, A. Sanai, F. Sanchez-Avila, J.F. Schiff, E. Schinazi, R. Sebastiani, G. Seguin-Devaux, C. Shanmugam, R.P. Sharara, A. Shilton, S. Shouval, D. Sievert, W. Simonova, M. Sohrabpour, A.A. Sonderup, M. Soza, A. Wendy Spearman, C. Steinfurth, N. Sulkowski, M. Tan, S.-S. Tanaka, J. Tashi, D. Thein, H.-H. Thompson, P. Tolmane, I. Toy, M. Valantinas, J. Van de Vijver, D. Vélez-Möller, P. Vince, A. Waked, I. Wang, S. Wedemeyer, H. Wong, V. Xie, Q. Yamada, S. Yang, H.-I. Yesmembetov, K. Yilmaz, Y. Younossi, Z. Yu, M.-L. Yuen, M.-F. Yurdaydin, C. Yusuf, A. Zekry, A. Zeuzem, S. Polaris Observatory Collaborators

The 69th World Health Assembly endorsed the Global Health Sector Strategy for Viral Hepatitis, embracing a goal to eliminate hepatitis infection as a public health threat by 2030. This was followed by the World Health Organization's (WHO) global targ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::e372284c07cc03239a409acf66c525eb
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3000058

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

Autor: Cooke, GS, Andrieux-Meyer, I, Applegate, TL, Atun, R, Burry, JR, Cheinquer, H, Dusheiko, G, Feld, JJ, Gore, C, Griswold, MG, Hamid, S, Hellard, ME, Hou, JL, Howell, J, Jia, J, Kravchenko, N, Lazarus, JV, Lemoine, M, Lesi, OA, Maistat, L, McMahon, BJ, Razavi, H, Roberts, TR, Simmons, B, Sonderup, MW, Spearman, CW, Taylor, BE, Thomas, DL, Waked, I, Ward, JW, Wiktor, SZ, Abdo, A, Aggarwal, R, Aghemo, A, Al-Judaibi, B, Al Mahtab, M, Altaf, A, Ameen, Z, Asselah, T, Baatarkkhuu, O, Barber, E, Barnes, E, Boulet, P, Burrows, L, Butsashvili, M, Chan, E, Chow, C, Cowie, B, Cunningham, C, De Araujo, A, Diap, G, Dore, G, Doyle, J, Elsayed, M, Fajardo, E, Gane, E, Getehun, A, Goldberg, D, Got, T, Hickman, M, Hill, A, Hutchinson, S, Jones, C, Kamili, S, Khan, A, Lee, A, Lee, TY, Malani, J, Morris, TM, Nayagam, S, Njouom, R, Ocama, P, Pedrana, A, Peeling, R, Reddy, A, Roberts, T, Sacks, J, Sarin, S, Shimakawa, Y, Silva, M, Skala, P, Taylor-Robinson, S, Thompson, A, Thursz, M, Tonganibeia, A, Wallace, J, Ward, J, Wolff, F, Vickerman, P, Yau, J

Publikováno v: Lancet Gastroenterology and Hepatology. 4(2)

Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV and tuberculosis. Highly effective prevention measures and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4889cdb00939f3068e3ad7b06580a351
http://ora.ox.ac.uk/objects/uuid:

2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference

Autor: Cornberg, M, Lok, As, Terrault, Na, Zoulim, F, Berg, T, Brunetto, Mr, Buchholz, S, Buti, M, Chan, Hl, Chang, Km, Dandri, M, Dusheiko, G, Feld, Jj, Ferrari, C, Ghany, M, Janssen, Hla, Kennedy, P, Lampertico, P, Liang, J, Locarnini, S, Maini, Mk, Mishra, P, Papatheodoridis, G, Petersen, J, Schlottmann, S, Wang, S, Wedemeyer, H.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3728::aa79ad730f315304667523f3c96f5ac0
http://hdl.handle.net/11568/1030187